136 related articles for article (PubMed ID: 31376571)
1. Gd-encapsulated carbonaceous dots for accurate characterization of tumor vessel permeability in magnetic resonance imaging.
Wu Y; Yan Y; Gao X; Yang L; Li Y; Guo X; Xie J; Wang K; Sun X
Nanomedicine; 2019 Oct; 21():102074. PubMed ID: 31376571
[TBL] [Abstract][Full Text] [Related]
2. Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer.
Wu Y; Li H; Yan Y; Wang K; Cheng Y; Li Y; Zhu X; Xie J; Sun X
Int J Nanomedicine; 2020; 15():4691-4703. PubMed ID: 32636625
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
[TBL] [Abstract][Full Text] [Related]
4. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
Cheng HL; Wallis C; Shou Z; Farhat WA
J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
[TBL] [Abstract][Full Text] [Related]
5. Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging.
Consolino L; Longo DL; Sciortino M; Dastrù W; Cabodi S; Giovenzana GB; Aime S
Gastric Cancer; 2017 Jul; 20(4):629-639. PubMed ID: 27995483
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
[TBL] [Abstract][Full Text] [Related]
7. Flow versus permeability weighting in estimating the forward volumetric transfer constant (K
Li CH; Chen FH; Schellingerhout D; Lin YS; Hong JH; Liu HL
Magn Reson Imaging; 2017 Feb; 36():105-111. PubMed ID: 27989901
[TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
9. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.
Ahn SJ; An CS; Koom WS; Song HT; Suh JS
Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
[TBL] [Abstract][Full Text] [Related]
11. Green Synthesis of Sub-10 nm Gadolinium-Based Nanoparticles for Sparkling Kidneys, Tumor, and Angiogenesis of Tumor-Bearing Mice in Magnetic Resonance Imaging.
Zhang B; Yang W; Yu J; Guo W; Wang J; Liu S; Xiao Y; Shi D
Adv Healthc Mater; 2017 Feb; 6(4):. PubMed ID: 28004887
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
[TBL] [Abstract][Full Text] [Related]
13. Image-guided selection of Gd@C-dots as sensitizers to improve radiotherapy of non-small cell lung cancer.
Ma X; Lee C; Zhang T; Cai J; Wang H; Jiang F; Wu Z; Xie J; Jiang G; Li Z
J Nanobiotechnology; 2021 Sep; 19(1):284. PubMed ID: 34551763
[TBL] [Abstract][Full Text] [Related]
14. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
[TBL] [Abstract][Full Text] [Related]
16. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
[TBL] [Abstract][Full Text] [Related]
18. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.
Consolino L; Longo DL; Dastrù W; Cutrin JC; Dettori D; Lanzardo S; Oliviero S; Cavallo F; Aime S
Int J Cancer; 2016 Jul; 139(2):404-13. PubMed ID: 26941084
[TBL] [Abstract][Full Text] [Related]
19. Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging.
Chen H; Wang GD; Tang W; Todd T; Zhen Z; Tsang C; Hekmatyar K; Cowger T; Hubbard R; Zhang W; Stickney J; Shen B; Xie J
Adv Mater; 2014 Oct; 26(39):6761-6766. PubMed ID: 25178894
[TBL] [Abstract][Full Text] [Related]
20. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]